» Articles » PMID: 39480754

Modification of MWCNTs with Bi2WO6 Nanoparticles Targeting IL-1β and NLRP3 Inflammasome Via Augmented Autophagy

Overview
Journal PLoS One
Date 2024 Oct 31
PMID 39480754
Authors
Affiliations
Soon will be listed here.
Abstract

This study reports the facile hydrothermal synthesis of pure Bi2WO6 and Bi2WO6\MWCNTs nanocomposite at specific molar ratio 1:2.5 of Bi2WO6:MWCNTs and elucidates their role in modulating the NLRP3 inflammasome pathway via autophagy induction. Comprehensive characterization techniques, including XRD, Raman, UV.Vis PL,FESEM,EDS and TEM, revealed the successful incorporation of MWCNTs into the Bi2WO6 structures, leading to enhanced crystattlinity, reduced band gap energy (2.4 eV) suppressed charge carrier recombination and mitigated nanoparticles aggregation. Notably, the reduced band gap facikitaed improved visible light harvesting, a crucial attribute for photocatalytic applications. Significantly, the nanocompsoite exhibited a remarkable capacity to augment autophagy in bone marrow-derived macrophages (BMDMs), consequently down-regulating the NLRP3 inflammasom activation and IL-1β secretion upon LPS and ATP stimulation. Immunofluorescence assays unveiled increased co-localization of LC3 and NLRP3, suggestion enhanced targeting of NLRP3 by autophagy. Inhibition of autophagy by 3-MA reversed these effects, confirming the pivotal role of autophagy induction. Furthermore, the nanocomposite attenuated caspase-1 activation and ASC oligomerzation, thereby impeding inflammasome assembly. Collectively, these findings underscore the potential of Bi2WO6\MWCNTs nanocompsite as a multifaceted therapeutic platform, levering its tailored optoelectronic properties and sbility to modulate the NLRP3 infalmmasome via autophagy augmentation. This work covers the way for the development of advanced nanomaterials with tunable functionalities for combating inflammatory disorders and antimicrobial applications.

References
1.
Zhao T, Wang Y, Deng Y, Fan X, Cao X, Hou L . Bicyclol Attenuates Acute Liver Injury by Activating Autophagy, Anti-Oxidative and Anti-Inflammatory Capabilities in Mice. Front Pharmacol. 2020; 11:463. PMC: 7181473. DOI: 10.3389/fphar.2020.00463. View

2.
Li Y, Liu J, Huang X, Yu J . Carbon-modified Bi(2)WO(6) nanostructures with improved photocatalytic activity under visible light. Dalton Trans. 2010; 39(14):3420-5. DOI: 10.1039/b924584g. View

3.
Kirkin V . History of the Selective Autophagy Research: How Did It Begin and Where Does It Stand Today?. J Mol Biol. 2019; 432(1):3-27. PMC: 6971693. DOI: 10.1016/j.jmb.2019.05.010. View

4.
Levine B, Kroemer G . Autophagy in the pathogenesis of disease. Cell. 2008; 132(1):27-42. PMC: 2696814. DOI: 10.1016/j.cell.2007.12.018. View

5.
Galluzzi L, Pietrocola F, Levine B, Kroemer G . Metabolic control of autophagy. Cell. 2014; 159(6):1263-76. PMC: 4500936. DOI: 10.1016/j.cell.2014.11.006. View